Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
At least a 1-year history of migraine with or without aura consistent with a diagnosis according to the ICHD-3, 2018.
Age of the participant at the time of migraine onset \< 50 years -History of 4 to 14 migraine days per month on average in the 3 months prior to Visit 1 in the investigator's judgment
Female participants willing to minimize the risk of inducing pregnancy for the duration of the clinical study and follow-up period. Male participants willing to minimize the risk of inducing pregnancy for the duration of the clinical study and follow-up period.
4 to 14 migraine days in the 28-day baseline period per eDiary
Failed oral migraine prophylaxis medications from 2 to 4 medication classes
You may not be if
Any clinically significant hematologic, endocrine, pulmonary, hepatic, gastrointestinal, or neurologic disease
Participant has any other concurrent pain condition that, in the opinion of the investigator, may significantly impact the current headache disorder
In the opinion of the investigator, confounding psychiatric conditions, dementia, epilepsy, or significant neurological disorders other than migraine
Has ≥ 15 headache days per month on average across the 3 months prior to Visit 1 in the investigator's judgment
Has ≥ 15 headache days in the 28-day baseline period per eDiary
Clinically significant cardiovascular or cerebrovascular disease
Has a history of migraine accompanied by diplopia or decreased level of consciousness or retinal migraine as defined by ICHD-3, 2018
Has a current diagnosis of chronic migraine, new persistent daily headache, medication overuse headache, trigeminal autonomic cephalgia (eg, cluster headache), or painful cranial neuropathy as defined by ICHD-3, 2018
